The Times Australia
News From Asia

.
Times Media

.

The United Laboratories International Holdings Limited Applies for the Clinical Trial of its Class 1 Innovative New Drug UBT251 Injection

HONG KONG SAR - Media OutReach - 20 June 2023 - On 15 June 2023, The United Bio-Technology (Hengqin) Co., Ltd. ("The United Bio-Technology"), a wholly-owned subsidiary of The United Laboratories International Holdings Limited ("TUL", the "Company" or the "Group"; Stock code: 3933), one of the leading pharmaceutical product manufacturers in the PRC, applied for the clinical trial of its self-developed class 1 innovative new drug UBT251 Injection on indications of adult type 2 diabetes, weight management and nonalcoholic fatty liver/nonalcoholic steatohepatitis ("NASH") and obtained the acceptance and payment notices by China National Medical Products Administration.



The Company is currently the first enterprise in China and the second enterprise in the world to apply for the clinical trial of a long-acting triple agonist of GLP-1 (glucagon-like peptide-1)/GIP (glucose-dependent insulinotropic polypeptide)/GCG (glucagon) prepared by chemical synthesis peptide.

UBT251 is a long-acting polypeptide drug that stimulates triple-target receptors for GLP-1/GIP /GCG simultaneously. By acting on GLP-1 receptors, GIP receptors and GCG receptors, UBT251 promotes insulin secretion, regulates appetite and energy metabolism, reduces blood glucose and weight, and improves liver steatosis. Preclinical studies in various animal models have proven that UBT251 significantly reduces blood glucose and weight, improves liver steatosis and fibrosis, and that it outperforms the marketed single-target GLP-1 receptor drug Semaglutide and the dual-target GLP-1/GIP drug Tirzepatide in the in-vivo treatment of model animals.

The product is expected to be beneficial for the treatment of patients with various metabolic disorders such as type 2 diabetes, overweight/obesity and NASH, when administered once a week by subcutaneous injection. At present, the fastest progress in the R&D of the same target drugs, both domestic and abroad, has just announced the initiation of phase III clinical trials.

Mr. Tsoi Hoi Shan, Chairman of the Group said that, "TUL has focused on the field of diabetes for several years and is one of the few pharmaceutical companies in China that owns both second and third generation insulin products. As the Group's biopharmaceutical R&D headquarters, The United Bio-Technology specialises in the research and development of drug products for energy metabolism, inflammation and autoimmune diseases. The primary mission of United Bio-Technology is the research and development of high-end biological drugs for the treatment of major chronic diseases. The United Bio-Technology's self-developed class 1 innovative new drug UBT251 Injection fully demonstrates the Group's innovation and R&D capability in biopharmaceutical industry. In the future, we will continue to actively promote the progress of new drug projects, and focus on enhancing its competitiveness and creativity in the biopharmaceutical industry, with a view of creating more benefits for the Company and its shareholders."

Hashtag: #TUL

The issuer is solely responsible for the content of this announcement.

About The United Laboratories International Holdings Limited (TUL)

TUL is one of the leading comprehensive pharmaceutical companies in China, principally engaged in the R&D, manufacturing and selling of finished products, bulk medicines and intermediate products. Its products include drugs for human use and animal healthcare. The Group has six production bases, and its sales teams for intermediate products, bulk medicines and finished products formed a broad sales network covering China and the rest of the world. Currently, TUL is one of the few pharmaceutical companies in China that owns both second and third generation insulin products. The Group is presently a constituent of the Hang Seng Composite Index Series and maintains MSCI ESG rating at A, which is an industry-leading rating.

The Times Features

The Gift That Keeps Growing: Why Tinybeans+ Gift Cards are a game-changer for new parents

As new parents navigate the joys and challenges of raising a child in the digital age, one question looms large: how do you preserve and share your baby's milestones without co...

Group Adventures Made Easy: How to Coordinate Shuttle Services from DCA to IAD

Traveling as a large group can be both exciting and challenging, especially when navigating busy airports like DCA (Ronald Reagan Washington National Airport) and IAD (Washington...

From Anxiety to Assurance: Proven Strategies to Support Your Child's Emotional Health

Navigating the intricate landscape of childhood emotions can be a daunting task for any parent, especially when faced with common fears and anxieties. However, transforming anxie...

The Rise of Meal Replacement Shakes in Australia: Why The Lady Shake Is Leading the Pack

Source Meal replacement shakes are having a moment in Australia, and it’s not hard to see why. They’re quick, convenient, and packed with nutrition, making them the perfect solu...

HCF’s Healthy Hearts Roadshow Wraps Up 2024 with a Final Regional Sprint

Next week marks the final leg of the HCF Healthy Hearts Roadshow for 2024, bringing free heart health checks to some of NSW’s most vibrant regional communities. As Australia’s ...

The Budget-Friendly Traveler: How Off-Airport Car Hire Can Save You Money

When planning a trip, transportation is one of the most crucial considerations. For many, the go-to option is renting a car at the airport for convenience. But what if we told ...

Times Magazine

Prevent Electrical Hazards With Key Safety Measures for Power Strip Circuit Breaker

As the reliance on technology increases, so does the number of electronic devices use on a daily basis. With this increase in electronic usage, the need for power strips has become more prevalent. Power strips are used as a convenient way to increa...

Essential Tips for Selecting the Best Bike Racks for Your Needs

Bike racks for surfers have grown in popularity in recent years, catering to the special needs of this niche industry. Surfers can use these racks to transport their boards to and from the beach without needing a larger vehicle or the inconvenience...

Lovely Blooms for Your Sweetheart on Valentine's Day

History of Valentine's Day Flowers Valentine’s Day is a special day of the year for many, as people show their affection for one another with gifts and kind words. One of the most popular items associated with this holiday is flowers, but do you k...

Property app Instarent

Property self-management soars during COVID lockdown The innovative PropTech app, Instarent, has seen exponential growth during the COVID -19 lockdown, reporting a 400 per cent increase in users during March/April 2020. These figures indicate ...

Types of EV Chargers

The world of electric vehicles is a confusing one, filled with abbreviations and acronyms that even the most seasoned EV drivers can't keep straight. It's also a rapidly changing landscape where cutting-edge technology is being developed at an in...

7 Digital Marketing Strategies To Factor Into Your Wider Online Campaign

While the modern digital marketplace is becoming ever more competitive, the good news is that there are countless ways in which you can market your brand, find your audience, and cut through all of the noise. And the best part? A large number of bu...